Literature DB >> 9117309

Expression of CD44 splice variants in colorectal cancer.

L S Wong1, J E Cantrill, A G Morris, I A Fraser.   

Abstract

BACKGROUND: The CD44 gene codes for a family of heavily glycosylated cell surface proteins that have been linked with tumour metastasis. The aim of the study was to analyse the expression of CD44 messenger RNA in colorectal cancer.
METHODS: The expression of CD44 variants 2 and 7 in colorectal tumour samples was compared with that in normal colon and lymphocytes from 59 patients using reverse transcription-polymerase chain reaction followed by blot hybridization with exon-specific probes, and a nested polymerase chain reaction.
RESULTS: All samples of tumour and metastatic tissue showed complex overexpression of many alternatively spliced products of the CD44 gene. Normal colon, liver and lymphocytes predominantly expressed the standard form of the CD44 molecule (CD44S) with low levels of two or three variants hybridizing to exons v2 and v7.
CONCLUSION: Deranged CD44 gene activity in colorectal cancer cells is confirmed. The analysis of CD44 gene expression may provide a promising marker for the early detection of colonic tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117309

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression.

Authors:  Rajeev K Boregowda; Hitesh N Appaiah; Mortha Karunakumar; Shivanna Parameshwariah; Geetha Avadani; Sunila Sunila; Shibdas Banerjee
Journal:  Tumour Biol       Date:  2012-10-26

2.  Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.

Authors:  Bogdan Zalewski
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.

Authors:  D Masson; M G Denis; P Lustenberger
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

4.  Detection of malignant cells in pleural fluid or ascites by CD44v8-10/CD44v10 competitive RT-PCR.

Authors:  M J Ahn; Y H Noh; H J Yoon; S C Yang; J W Sohn; J H Choi; Y Y Lee; I Y Choi; I S Kim; Y S Lee; C K Park
Journal:  Korean J Intern Med       Date:  2001-03       Impact factor: 2.884

5.  Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.

Authors:  Haifeng Lian; Aili Wang; Yuanyuan Shen; Qian Wang; Zhenru Zhou; Ranran Zhang; Kun Li; Chengxia Liu; Hongtao Jia
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

6.  Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression.

Authors:  Livia Raso-Barnett; Balazs Banky; Tamas Barbai; Peter Becsagh; Jozsef Timar; Erzsebet Raso
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

7.  Clinicopathological significance and prognostic implication of CD44 and its splice variants (v3 and v6) in colorectal cancer.

Authors:  Bing Yan; Ying Mu; Meiqi Cui; Long Liu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.